nodes	percent_of_prediction	percent_of_DWPC	metapath
Acamprosate—GRIN3B—lung—systemic lupus erythematosus	0.013	0.083	CbGeAlD
Acamprosate—GRM5—nervous system—systemic lupus erythematosus	0.00759	0.0485	CbGeAlD
Acamprosate—GRM5—central nervous system—systemic lupus erythematosus	0.00731	0.0467	CbGeAlD
Acamprosate—SLC36A1—nephron tubule—systemic lupus erythematosus	0.00689	0.044	CbGeAlD
Acamprosate—GRIN2D—tendon—systemic lupus erythematosus	0.00662	0.0422	CbGeAlD
Acamprosate—SLC36A1—kidney—systemic lupus erythematosus	0.00605	0.0386	CbGeAlD
Acamprosate—SLC36A1—cortex of kidney—systemic lupus erythematosus	0.0059	0.0376	CbGeAlD
Acamprosate—GRIN2C—nervous system—systemic lupus erythematosus	0.00579	0.0369	CbGeAlD
Acamprosate—GRIN2C—central nervous system—systemic lupus erythematosus	0.00557	0.0355	CbGeAlD
Acamprosate—GRIN2D—nervous system—systemic lupus erythematosus	0.00538	0.0343	CbGeAlD
Acamprosate—GRIN2D—central nervous system—systemic lupus erythematosus	0.00518	0.033	CbGeAlD
Acamprosate—GRIN3A—nervous system—systemic lupus erythematosus	0.00506	0.0323	CbGeAlD
Acamprosate—GRIN2A—tendon—systemic lupus erythematosus	0.00492	0.0314	CbGeAlD
Acamprosate—SLC36A1—tendon—systemic lupus erythematosus	0.00489	0.0312	CbGeAlD
Acamprosate—GRIN3A—central nervous system—systemic lupus erythematosus	0.00487	0.0311	CbGeAlD
Acamprosate—GRIN1—nervous system—systemic lupus erythematosus	0.00479	0.0306	CbGeAlD
Acamprosate—SLC36A1—bone marrow—systemic lupus erythematosus	0.00474	0.0302	CbGeAlD
Acamprosate—GRIN1—central nervous system—systemic lupus erythematosus	0.00462	0.0295	CbGeAlD
Acamprosate—GRIN2B—nervous system—systemic lupus erythematosus	0.00457	0.0292	CbGeAlD
Acamprosate—GRIN2B—central nervous system—systemic lupus erythematosus	0.0044	0.0281	CbGeAlD
Acamprosate—SLC36A1—lung—systemic lupus erythematosus	0.00429	0.0274	CbGeAlD
Acamprosate—GRIN2A—nervous system—systemic lupus erythematosus	0.004	0.0255	CbGeAlD
Acamprosate—SLC36A1—nervous system—systemic lupus erythematosus	0.00397	0.0254	CbGeAlD
Acamprosate—GRIN2A—central nervous system—systemic lupus erythematosus	0.00385	0.0246	CbGeAlD
Acamprosate—SLC36A1—central nervous system—systemic lupus erythematosus	0.00382	0.0244	CbGeAlD
Acamprosate—GABRB3—connective tissue—systemic lupus erythematosus	0.00346	0.0221	CbGeAlD
Acamprosate—GABRG2—nervous system—systemic lupus erythematosus	0.00252	0.0161	CbGeAlD
Acamprosate—GABRG2—central nervous system—systemic lupus erythematosus	0.00242	0.0155	CbGeAlD
Acamprosate—GABRA1—nervous system—systemic lupus erythematosus	0.00222	0.0142	CbGeAlD
Acamprosate—GABRA1—central nervous system—systemic lupus erythematosus	0.00214	0.0137	CbGeAlD
Acamprosate—GABRB3—lung—systemic lupus erythematosus	0.00209	0.0133	CbGeAlD
Acamprosate—GABRB3—nervous system—systemic lupus erythematosus	0.00193	0.0123	CbGeAlD
Acamprosate—GABRB3—central nervous system—systemic lupus erythematosus	0.00186	0.0119	CbGeAlD
Acamprosate—SLC36A1—Amino acid and oligopeptide SLC transporters—SLC15A4—systemic lupus erythematosus	0.00139	0.113	CbGpPWpGaD
Acamprosate—SLC36A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A4—systemic lupus erythematosus	0.000817	0.0666	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—TNFSF13B—systemic lupus erythematosus	0.000474	0.0386	CbGpPWpGaD
Acamprosate—Anxiety—Betamethasone—systemic lupus erythematosus	0.000413	0.000497	CcSEcCtD
Acamprosate—Discomfort—Dexamethasone—systemic lupus erythematosus	0.00041	0.000493	CcSEcCtD
Acamprosate—Discomfort—Betamethasone—systemic lupus erythematosus	0.00041	0.000493	CcSEcCtD
Acamprosate—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	0.000409	0.000493	CcSEcCtD
Acamprosate—Haemoglobin—Methotrexate—systemic lupus erythematosus	0.000409	0.000492	CcSEcCtD
Acamprosate—Hypotension—Methylprednisolone—systemic lupus erythematosus	0.000408	0.000491	CcSEcCtD
Acamprosate—Pain—Prednisolone—systemic lupus erythematosus	0.000407	0.00049	CcSEcCtD
Acamprosate—Haemorrhage—Methotrexate—systemic lupus erythematosus	0.000407	0.00049	CcSEcCtD
Acamprosate—Hepatitis—Methotrexate—systemic lupus erythematosus	0.000407	0.00049	CcSEcCtD
Acamprosate—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	0.000406	0.000488	CcSEcCtD
Acamprosate—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	0.000404	0.000487	CcSEcCtD
Acamprosate—Pharyngitis—Methotrexate—systemic lupus erythematosus	0.000404	0.000486	CcSEcCtD
Acamprosate—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000404	0.000486	CcSEcCtD
Acamprosate—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000404	0.000486	CcSEcCtD
Acamprosate—Nausea—Leflunomide—systemic lupus erythematosus	0.000403	0.000485	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.000402	0.000483	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	0.000399	0.00048	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	0.000398	0.000479	CcSEcCtD
Acamprosate—Pain—Hydrocortisone—systemic lupus erythematosus	0.000398	0.000479	CcSEcCtD
Acamprosate—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	0.000397	0.000478	CcSEcCtD
Acamprosate—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	0.000397	0.000478	CcSEcCtD
Acamprosate—Insomnia—Triamcinolone—systemic lupus erythematosus	0.000396	0.000477	CcSEcCtD
Acamprosate—Insomnia—Methylprednisolone—systemic lupus erythematosus	0.000395	0.000476	CcSEcCtD
Acamprosate—Infection—Dexamethasone—systemic lupus erythematosus	0.000395	0.000475	CcSEcCtD
Acamprosate—Infection—Betamethasone—systemic lupus erythematosus	0.000395	0.000475	CcSEcCtD
Acamprosate—Ill-defined disorder—Prednisone—systemic lupus erythematosus	0.000393	0.000473	CcSEcCtD
Acamprosate—Paraesthesia—Triamcinolone—systemic lupus erythematosus	0.000393	0.000473	CcSEcCtD
Acamprosate—Feeling abnormal—Prednisolone—systemic lupus erythematosus	0.000392	0.000472	CcSEcCtD
Acamprosate—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	0.000392	0.000472	CcSEcCtD
Acamprosate—Visual impairment—Methotrexate—systemic lupus erythematosus	0.000392	0.000472	CcSEcCtD
Acamprosate—Anaemia—Prednisone—systemic lupus erythematosus	0.000392	0.000472	CcSEcCtD
Acamprosate—Shock—Dexamethasone—systemic lupus erythematosus	0.000391	0.00047	CcSEcCtD
Acamprosate—Shock—Betamethasone—systemic lupus erythematosus	0.000391	0.00047	CcSEcCtD
Acamprosate—Dyspnoea—Triamcinolone—systemic lupus erythematosus	0.00039	0.00047	CcSEcCtD
Acamprosate—Agitation—Prednisone—systemic lupus erythematosus	0.00039	0.000469	CcSEcCtD
Acamprosate—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	0.000389	0.000468	CcSEcCtD
Acamprosate—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	0.000389	0.000468	CcSEcCtD
Acamprosate—Tachycardia—Betamethasone—systemic lupus erythematosus	0.000388	0.000467	CcSEcCtD
Acamprosate—Tachycardia—Dexamethasone—systemic lupus erythematosus	0.000388	0.000467	CcSEcCtD
Acamprosate—Angioedema—Prednisone—systemic lupus erythematosus	0.000387	0.000466	CcSEcCtD
Acamprosate—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.000386	0.000464	CcSEcCtD
Acamprosate—Dyspepsia—Triamcinolone—systemic lupus erythematosus	0.000386	0.000464	CcSEcCtD
Acamprosate—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	0.000385	0.000463	CcSEcCtD
Acamprosate—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	0.000384	0.000462	CcSEcCtD
Acamprosate—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	0.000384	0.000462	CcSEcCtD
Acamprosate—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	0.000383	0.000461	CcSEcCtD
Acamprosate—Malaise—Prednisone—systemic lupus erythematosus	0.000382	0.00046	CcSEcCtD
Acamprosate—Vertigo—Prednisone—systemic lupus erythematosus	0.000381	0.000458	CcSEcCtD
Acamprosate—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	0.00038	0.000458	CcSEcCtD
Acamprosate—Syncope—Prednisone—systemic lupus erythematosus	0.00038	0.000458	CcSEcCtD
Acamprosate—Tinnitus—Methotrexate—systemic lupus erythematosus	0.00038	0.000457	CcSEcCtD
Acamprosate—Anorexia—Dexamethasone—systemic lupus erythematosus	0.000379	0.000456	CcSEcCtD
Acamprosate—Anorexia—Betamethasone—systemic lupus erythematosus	0.000379	0.000456	CcSEcCtD
Acamprosate—Urticaria—Prednisolone—systemic lupus erythematosus	0.000378	0.000455	CcSEcCtD
Acamprosate—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.000376	0.000453	CcSEcCtD
Acamprosate—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000375	0.000452	CcSEcCtD
Acamprosate—Pain—Triamcinolone—systemic lupus erythematosus	0.000375	0.000451	CcSEcCtD
Acamprosate—Loss of consciousness—Prednisone—systemic lupus erythematosus	0.000373	0.000448	CcSEcCtD
Acamprosate—Hypotension—Dexamethasone—systemic lupus erythematosus	0.000371	0.000447	CcSEcCtD
Acamprosate—Hypotension—Betamethasone—systemic lupus erythematosus	0.000371	0.000447	CcSEcCtD
Acamprosate—Pruritus—Cyclosporine—systemic lupus erythematosus	0.00037	0.000446	CcSEcCtD
Acamprosate—Urticaria—Hydrocortisone—systemic lupus erythematosus	0.000369	0.000445	CcSEcCtD
Acamprosate—Immune system disorder—Methotrexate—systemic lupus erythematosus	0.000368	0.000442	CcSEcCtD
Acamprosate—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	0.000368	0.000442	CcSEcCtD
Acamprosate—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	0.000368	0.000442	CcSEcCtD
Acamprosate—Convulsion—Prednisone—systemic lupus erythematosus	0.000367	0.000442	CcSEcCtD
Acamprosate—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000366	0.000441	CcSEcCtD
Acamprosate—Hypertension—Prednisone—systemic lupus erythematosus	0.000366	0.000441	CcSEcCtD
Acamprosate—SLC36A1—SLC-mediated transmembrane transport—SLC15A4—systemic lupus erythematosus	0.000365	0.0297	CbGpPWpGaD
Acamprosate—Chills—Methotrexate—systemic lupus erythematosus	0.000365	0.00044	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	0.000362	0.000436	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	0.000362	0.000436	CcSEcCtD
Acamprosate—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.000361	0.000435	CcSEcCtD
Acamprosate—Myalgia—Prednisone—systemic lupus erythematosus	0.000361	0.000434	CcSEcCtD
Acamprosate—Arthralgia—Prednisone—systemic lupus erythematosus	0.000361	0.000434	CcSEcCtD
Acamprosate—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	0.000361	0.000434	CcSEcCtD
Acamprosate—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	0.00036	0.000433	CcSEcCtD
Acamprosate—Anxiety—Prednisone—systemic lupus erythematosus	0.00036	0.000433	CcSEcCtD
Acamprosate—Alopecia—Methotrexate—systemic lupus erythematosus	0.00036	0.000433	CcSEcCtD
Acamprosate—Insomnia—Dexamethasone—systemic lupus erythematosus	0.000359	0.000433	CcSEcCtD
Acamprosate—Insomnia—Betamethasone—systemic lupus erythematosus	0.000359	0.000433	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	0.000359	0.000431	CcSEcCtD
Acamprosate—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000358	0.000431	CcSEcCtD
Acamprosate—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	0.000357	0.00043	CcSEcCtD
Acamprosate—Paraesthesia—Dexamethasone—systemic lupus erythematosus	0.000357	0.000429	CcSEcCtD
Acamprosate—Paraesthesia—Betamethasone—systemic lupus erythematosus	0.000357	0.000429	CcSEcCtD
Acamprosate—Discomfort—Prednisone—systemic lupus erythematosus	0.000357	0.000429	CcSEcCtD
Acamprosate—Mental disorder—Methotrexate—systemic lupus erythematosus	0.000357	0.000429	CcSEcCtD
Acamprosate—Malnutrition—Methotrexate—systemic lupus erythematosus	0.000354	0.000426	CcSEcCtD
Acamprosate—Hypersensitivity—Prednisolone—systemic lupus erythematosus	0.000351	0.000422	CcSEcCtD
Acamprosate—Dyspepsia—Betamethasone—systemic lupus erythematosus	0.00035	0.000421	CcSEcCtD
Acamprosate—Dyspepsia—Dexamethasone—systemic lupus erythematosus	0.00035	0.000421	CcSEcCtD
Acamprosate—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000349	0.00042	CcSEcCtD
Acamprosate—Urticaria—Triamcinolone—systemic lupus erythematosus	0.000348	0.000419	CcSEcCtD
Acamprosate—Urticaria—Methylprednisolone—systemic lupus erythematosus	0.000347	0.000418	CcSEcCtD
Acamprosate—Dysgeusia—Methotrexate—systemic lupus erythematosus	0.000347	0.000418	CcSEcCtD
Acamprosate—Body temperature increased—Triamcinolone—systemic lupus erythematosus	0.000346	0.000417	CcSEcCtD
Acamprosate—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000346	0.000416	CcSEcCtD
Acamprosate—Anaphylactic shock—Prednisone—systemic lupus erythematosus	0.000346	0.000416	CcSEcCtD
Acamprosate—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	0.000345	0.000416	CcSEcCtD
Acamprosate—Decreased appetite—Betamethasone—systemic lupus erythematosus	0.000345	0.000416	CcSEcCtD
Acamprosate—Decreased appetite—Dexamethasone—systemic lupus erythematosus	0.000345	0.000416	CcSEcCtD
Acamprosate—Infection—Prednisone—systemic lupus erythematosus	0.000344	0.000414	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.000343	0.000413	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.000343	0.000413	CcSEcCtD
Acamprosate—Back pain—Methotrexate—systemic lupus erythematosus	0.000343	0.000412	CcSEcCtD
Acamprosate—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	0.000343	0.000412	CcSEcCtD
Acamprosate—Shock—Prednisone—systemic lupus erythematosus	0.00034	0.00041	CcSEcCtD
Acamprosate—Pain—Dexamethasone—systemic lupus erythematosus	0.00034	0.000409	CcSEcCtD
Acamprosate—Pain—Betamethasone—systemic lupus erythematosus	0.00034	0.000409	CcSEcCtD
Acamprosate—Tachycardia—Prednisone—systemic lupus erythematosus	0.000338	0.000406	CcSEcCtD
Acamprosate—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.000338	0.000406	CcSEcCtD
Acamprosate—Skin disorder—Prednisone—systemic lupus erythematosus	0.000336	0.000405	CcSEcCtD
Acamprosate—Hyperhidrosis—Prednisone—systemic lupus erythematosus	0.000335	0.000403	CcSEcCtD
Acamprosate—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000334	0.000402	CcSEcCtD
Acamprosate—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000333	0.0004	CcSEcCtD
Acamprosate—GRIN1—EPHB-mediated forward signaling—LYN—systemic lupus erythematosus	0.000331	0.0269	CbGpPWpGaD
Acamprosate—Rash—Cyclosporine—systemic lupus erythematosus	0.00033	0.000397	CcSEcCtD
Acamprosate—Anorexia—Prednisone—systemic lupus erythematosus	0.00033	0.000397	CcSEcCtD
Acamprosate—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.00033	0.000397	CcSEcCtD
Acamprosate—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.000329	0.000396	CcSEcCtD
Acamprosate—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	0.000329	0.000396	CcSEcCtD
Acamprosate—Headache—Cyclosporine—systemic lupus erythematosus	0.000328	0.000395	CcSEcCtD
Acamprosate—Anaemia—Methotrexate—systemic lupus erythematosus	0.000328	0.000394	CcSEcCtD
Acamprosate—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	0.000327	0.000394	CcSEcCtD
Acamprosate—Feeling abnormal—Betamethasone—systemic lupus erythematosus	0.000327	0.000394	CcSEcCtD
Acamprosate—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	0.000325	0.000391	CcSEcCtD
Acamprosate—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	0.000325	0.000391	CcSEcCtD
Acamprosate—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.000325	0.000391	CcSEcCtD
Acamprosate—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	0.000323	0.000388	CcSEcCtD
Acamprosate—GRIN2B—EPHB-mediated forward signaling—LYN—systemic lupus erythematosus	0.000323	0.0263	CbGpPWpGaD
Acamprosate—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	0.000322	0.000387	CcSEcCtD
Acamprosate—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.000322	0.000387	CcSEcCtD
Acamprosate—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000322	0.000387	CcSEcCtD
Acamprosate—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.00032	0.000385	CcSEcCtD
Acamprosate—Malaise—Methotrexate—systemic lupus erythematosus	0.00032	0.000385	CcSEcCtD
Acamprosate—Vertigo—Methotrexate—systemic lupus erythematosus	0.000318	0.000383	CcSEcCtD
Acamprosate—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.000318	0.000383	CcSEcCtD
Acamprosate—Leukopenia—Methotrexate—systemic lupus erythematosus	0.000317	0.000382	CcSEcCtD
Acamprosate—Urticaria—Betamethasone—systemic lupus erythematosus	0.000316	0.00038	CcSEcCtD
Acamprosate—Urticaria—Dexamethasone—systemic lupus erythematosus	0.000316	0.00038	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	0.000315	0.000379	CcSEcCtD
Acamprosate—Dizziness—Prednisolone—systemic lupus erythematosus	0.000315	0.000379	CcSEcCtD
Acamprosate—Asthenia—Triamcinolone—systemic lupus erythematosus	0.000314	0.000378	CcSEcCtD
Acamprosate—Abdominal pain—Dexamethasone—systemic lupus erythematosus	0.000314	0.000378	CcSEcCtD
Acamprosate—Body temperature increased—Dexamethasone—systemic lupus erythematosus	0.000314	0.000378	CcSEcCtD
Acamprosate—Body temperature increased—Betamethasone—systemic lupus erythematosus	0.000314	0.000378	CcSEcCtD
Acamprosate—Abdominal pain—Betamethasone—systemic lupus erythematosus	0.000314	0.000378	CcSEcCtD
Acamprosate—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.000314	0.000377	CcSEcCtD
Acamprosate—Insomnia—Prednisone—systemic lupus erythematosus	0.000313	0.000377	CcSEcCtD
Acamprosate—Nausea—Cyclosporine—systemic lupus erythematosus	0.000311	0.000374	CcSEcCtD
Acamprosate—Paraesthesia—Prednisone—systemic lupus erythematosus	0.000311	0.000374	CcSEcCtD
Acamprosate—Pruritus—Triamcinolone—systemic lupus erythematosus	0.00031	0.000373	CcSEcCtD
Acamprosate—Cough—Methotrexate—systemic lupus erythematosus	0.000309	0.000372	CcSEcCtD
Acamprosate—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.000309	0.000372	CcSEcCtD
Acamprosate—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000308	0.00037	CcSEcCtD
Acamprosate—Convulsion—Methotrexate—systemic lupus erythematosus	0.000307	0.000369	CcSEcCtD
Acamprosate—Dyspepsia—Prednisone—systemic lupus erythematosus	0.000305	0.000367	CcSEcCtD
Acamprosate—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000303	0.000365	CcSEcCtD
Acamprosate—Chest pain—Methotrexate—systemic lupus erythematosus	0.000302	0.000363	CcSEcCtD
Acamprosate—Arthralgia—Methotrexate—systemic lupus erythematosus	0.000302	0.000363	CcSEcCtD
Acamprosate—Myalgia—Methotrexate—systemic lupus erythematosus	0.000302	0.000363	CcSEcCtD
Acamprosate—Decreased appetite—Prednisone—systemic lupus erythematosus	0.000301	0.000362	CcSEcCtD
Acamprosate—Rash—Prednisolone—systemic lupus erythematosus	0.0003	0.000361	CcSEcCtD
Acamprosate—Dermatitis—Prednisolone—systemic lupus erythematosus	0.0003	0.000361	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	0.0003	0.000361	CcSEcCtD
Acamprosate—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.000299	0.00036	CcSEcCtD
Acamprosate—Headache—Prednisolone—systemic lupus erythematosus	0.000298	0.000359	CcSEcCtD
Acamprosate—Discomfort—Methotrexate—systemic lupus erythematosus	0.000298	0.000359	CcSEcCtD
Acamprosate—Constipation—Prednisone—systemic lupus erythematosus	0.000296	0.000356	CcSEcCtD
Acamprosate—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.000296	0.000356	CcSEcCtD
Acamprosate—Rash—Hydrocortisone—systemic lupus erythematosus	0.000293	0.000353	CcSEcCtD
Acamprosate—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.000293	0.000353	CcSEcCtD
Acamprosate—Confusional state—Methotrexate—systemic lupus erythematosus	0.000292	0.000351	CcSEcCtD
Acamprosate—Headache—Hydrocortisone—systemic lupus erythematosus	0.000291	0.000351	CcSEcCtD
Acamprosate—Dizziness—Triamcinolone—systemic lupus erythematosus	0.00029	0.000349	CcSEcCtD
Acamprosate—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	0.000289	0.000348	CcSEcCtD
Acamprosate—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000289	0.000348	CcSEcCtD
Acamprosate—Infection—Methotrexate—systemic lupus erythematosus	0.000287	0.000346	CcSEcCtD
Acamprosate—Feeling abnormal—Prednisone—systemic lupus erythematosus	0.000285	0.000343	CcSEcCtD
Acamprosate—Asthenia—Dexamethasone—systemic lupus erythematosus	0.000285	0.000343	CcSEcCtD
Acamprosate—Asthenia—Betamethasone—systemic lupus erythematosus	0.000285	0.000343	CcSEcCtD
Acamprosate—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	0.000283	0.000341	CcSEcCtD
Acamprosate—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	0.000283	0.000341	CcSEcCtD
Acamprosate—Nausea—Prednisolone—systemic lupus erythematosus	0.000283	0.00034	CcSEcCtD
Acamprosate—Pruritus—Betamethasone—systemic lupus erythematosus	0.000281	0.000338	CcSEcCtD
Acamprosate—Pruritus—Dexamethasone—systemic lupus erythematosus	0.000281	0.000338	CcSEcCtD
Acamprosate—Skin disorder—Methotrexate—systemic lupus erythematosus	0.000281	0.000338	CcSEcCtD
Acamprosate—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	0.00028	0.000336	CcSEcCtD
Acamprosate—Vomiting—Triamcinolone—systemic lupus erythematosus	0.000278	0.000335	CcSEcCtD
Acamprosate—Vomiting—Methylprednisolone—systemic lupus erythematosus	0.000278	0.000334	CcSEcCtD
Acamprosate—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000276	0.000332	CcSEcCtD
Acamprosate—Rash—Triamcinolone—systemic lupus erythematosus	0.000276	0.000332	CcSEcCtD
Acamprosate—Dermatitis—Triamcinolone—systemic lupus erythematosus	0.000276	0.000332	CcSEcCtD
Acamprosate—Anorexia—Methotrexate—systemic lupus erythematosus	0.000276	0.000332	CcSEcCtD
Acamprosate—Rash—Methylprednisolone—systemic lupus erythematosus	0.000276	0.000332	CcSEcCtD
Acamprosate—Dermatitis—Methylprednisolone—systemic lupus erythematosus	0.000275	0.000331	CcSEcCtD
Acamprosate—Urticaria—Prednisone—systemic lupus erythematosus	0.000275	0.000331	CcSEcCtD
Acamprosate—Headache—Triamcinolone—systemic lupus erythematosus	0.000274	0.00033	CcSEcCtD
Acamprosate—Headache—Methylprednisolone—systemic lupus erythematosus	0.000274	0.000329	CcSEcCtD
Acamprosate—Abdominal pain—Prednisone—systemic lupus erythematosus	0.000274	0.000329	CcSEcCtD
Acamprosate—Body temperature increased—Prednisone—systemic lupus erythematosus	0.000274	0.000329	CcSEcCtD
Acamprosate—Diarrhoea—Betamethasone—systemic lupus erythematosus	0.000272	0.000327	CcSEcCtD
Acamprosate—Diarrhoea—Dexamethasone—systemic lupus erythematosus	0.000272	0.000327	CcSEcCtD
Acamprosate—Hypotension—Methotrexate—systemic lupus erythematosus	0.00027	0.000325	CcSEcCtD
Acamprosate—GRIN2B—ErbB4 signaling events—PRL—systemic lupus erythematosus	0.000266	0.0217	CbGpPWpGaD
Acamprosate—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	0.000264	0.000317	CcSEcCtD
Acamprosate—Dizziness—Dexamethasone—systemic lupus erythematosus	0.000263	0.000316	CcSEcCtD
Acamprosate—Dizziness—Betamethasone—systemic lupus erythematosus	0.000263	0.000316	CcSEcCtD
Acamprosate—Insomnia—Methotrexate—systemic lupus erythematosus	0.000262	0.000315	CcSEcCtD
Acamprosate—Nausea—Triamcinolone—systemic lupus erythematosus	0.00026	0.000313	CcSEcCtD
Acamprosate—Paraesthesia—Methotrexate—systemic lupus erythematosus	0.00026	0.000313	CcSEcCtD
Acamprosate—Nausea—Methylprednisolone—systemic lupus erythematosus	0.00026	0.000312	CcSEcCtD
Acamprosate—Dyspnoea—Methotrexate—systemic lupus erythematosus	0.000258	0.00031	CcSEcCtD
Acamprosate—Somnolence—Methotrexate—systemic lupus erythematosus	0.000257	0.000309	CcSEcCtD
Acamprosate—Hypersensitivity—Prednisone—systemic lupus erythematosus	0.000255	0.000307	CcSEcCtD
Acamprosate—Dyspepsia—Methotrexate—systemic lupus erythematosus	0.000255	0.000306	CcSEcCtD
Acamprosate—Vomiting—Dexamethasone—systemic lupus erythematosus	0.000253	0.000304	CcSEcCtD
Acamprosate—Vomiting—Betamethasone—systemic lupus erythematosus	0.000253	0.000304	CcSEcCtD
Acamprosate—Decreased appetite—Methotrexate—systemic lupus erythematosus	0.000251	0.000303	CcSEcCtD
Acamprosate—Rash—Betamethasone—systemic lupus erythematosus	0.000251	0.000302	CcSEcCtD
Acamprosate—Rash—Dexamethasone—systemic lupus erythematosus	0.000251	0.000302	CcSEcCtD
Acamprosate—Dermatitis—Dexamethasone—systemic lupus erythematosus	0.00025	0.000301	CcSEcCtD
Acamprosate—Dermatitis—Betamethasone—systemic lupus erythematosus	0.00025	0.000301	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	0.00025	0.0003	CcSEcCtD
Acamprosate—Headache—Dexamethasone—systemic lupus erythematosus	0.000249	0.0003	CcSEcCtD
Acamprosate—Headache—Betamethasone—systemic lupus erythematosus	0.000249	0.0003	CcSEcCtD
Acamprosate—Asthenia—Prednisone—systemic lupus erythematosus	0.000248	0.000299	CcSEcCtD
Acamprosate—Pain—Methotrexate—systemic lupus erythematosus	0.000247	0.000298	CcSEcCtD
Acamprosate—Pruritus—Prednisone—systemic lupus erythematosus	0.000245	0.000295	CcSEcCtD
Acamprosate—Feeling abnormal—Methotrexate—systemic lupus erythematosus	0.000238	0.000287	CcSEcCtD
Acamprosate—Diarrhoea—Prednisone—systemic lupus erythematosus	0.000237	0.000285	CcSEcCtD
Acamprosate—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	0.000237	0.000285	CcSEcCtD
Acamprosate—Nausea—Dexamethasone—systemic lupus erythematosus	0.000236	0.000284	CcSEcCtD
Acamprosate—Nausea—Betamethasone—systemic lupus erythematosus	0.000236	0.000284	CcSEcCtD
Acamprosate—Urticaria—Methotrexate—systemic lupus erythematosus	0.00023	0.000276	CcSEcCtD
Acamprosate—Dizziness—Prednisone—systemic lupus erythematosus	0.000229	0.000275	CcSEcCtD
Acamprosate—Abdominal pain—Methotrexate—systemic lupus erythematosus	0.000229	0.000275	CcSEcCtD
Acamprosate—Body temperature increased—Methotrexate—systemic lupus erythematosus	0.000229	0.000275	CcSEcCtD
Acamprosate—Vomiting—Prednisone—systemic lupus erythematosus	0.00022	0.000265	CcSEcCtD
Acamprosate—Rash—Prednisone—systemic lupus erythematosus	0.000218	0.000263	CcSEcCtD
Acamprosate—Dermatitis—Prednisone—systemic lupus erythematosus	0.000218	0.000262	CcSEcCtD
Acamprosate—Headache—Prednisone—systemic lupus erythematosus	0.000217	0.000261	CcSEcCtD
Acamprosate—Hypersensitivity—Methotrexate—systemic lupus erythematosus	0.000213	0.000256	CcSEcCtD
Acamprosate—Asthenia—Methotrexate—systemic lupus erythematosus	0.000208	0.00025	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—TNFSF13—systemic lupus erythematosus	0.000206	0.0168	CbGpPWpGaD
Acamprosate—Nausea—Prednisone—systemic lupus erythematosus	0.000206	0.000247	CcSEcCtD
Acamprosate—Pruritus—Methotrexate—systemic lupus erythematosus	0.000205	0.000246	CcSEcCtD
Acamprosate—Diarrhoea—Methotrexate—systemic lupus erythematosus	0.000198	0.000238	CcSEcCtD
Acamprosate—Dizziness—Methotrexate—systemic lupus erythematosus	0.000191	0.00023	CcSEcCtD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	0.000186	0.0151	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—C4B—systemic lupus erythematosus	0.000185	0.0151	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—C4A—systemic lupus erythematosus	0.000185	0.0151	CbGpPWpGaD
Acamprosate—Vomiting—Methotrexate—systemic lupus erythematosus	0.000184	0.000221	CcSEcCtD
Acamprosate—Rash—Methotrexate—systemic lupus erythematosus	0.000182	0.000219	CcSEcCtD
Acamprosate—Dermatitis—Methotrexate—systemic lupus erythematosus	0.000182	0.000219	CcSEcCtD
Acamprosate—Headache—Methotrexate—systemic lupus erythematosus	0.000181	0.000218	CcSEcCtD
Acamprosate—GRM5—G alpha (q) signalling events—RASGRP1—systemic lupus erythematosus	0.000173	0.0141	CbGpPWpGaD
Acamprosate—Nausea—Methotrexate—systemic lupus erythematosus	0.000172	0.000207	CcSEcCtD
Acamprosate—GRIN1—EPH-Ephrin signaling—LYN—systemic lupus erythematosus	0.00017	0.0139	CbGpPWpGaD
Acamprosate—GRIN2B—EPH-Ephrin signaling—LYN—systemic lupus erythematosus	0.000166	0.0135	CbGpPWpGaD
Acamprosate—GRIN2C—Alzheimers Disease—FAS—systemic lupus erythematosus	0.000161	0.0131	CbGpPWpGaD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—systemic lupus erythematosus	0.000155	0.0126	CbGpPWpGaD
Acamprosate—GRIN2D—Alzheimers Disease—FAS—systemic lupus erythematosus	0.000149	0.0122	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—FCGR2A—systemic lupus erythematosus	0.00014	0.0114	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—P2RY12—systemic lupus erythematosus	0.000139	0.0113	CbGpPWpGaD
Acamprosate—GRIN2A—Alzheimers Disease—FAS—systemic lupus erythematosus	0.000123	0.00999	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—NCF2—systemic lupus erythematosus	0.000122	0.00993	CbGpPWpGaD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—JAK1—systemic lupus erythematosus	0.00012	0.00978	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—GADD45A—systemic lupus erythematosus	0.000119	0.00969	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—NCF2—systemic lupus erythematosus	0.000119	0.00968	CbGpPWpGaD
Acamprosate—GRM5—G alpha (q) signalling events—F2—systemic lupus erythematosus	0.000109	0.00889	CbGpPWpGaD
Acamprosate—GRIN1—Alzheimers Disease—FAS—systemic lupus erythematosus	0.000107	0.00872	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—C4A—systemic lupus erythematosus	0.000105	0.00853	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—C4B—systemic lupus erythematosus	0.000105	0.00853	CbGpPWpGaD
Acamprosate—GRIN2B—Alzheimers Disease—FAS—systemic lupus erythematosus	0.000104	0.0085	CbGpPWpGaD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—F2—systemic lupus erythematosus	9.76e-05	0.00795	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL1RN—systemic lupus erythematosus	9.68e-05	0.00788	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—CXCL12—systemic lupus erythematosus	9.36e-05	0.00762	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IL4—systemic lupus erythematosus	8.43e-05	0.00686	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—NCF2—systemic lupus erythematosus	8.04e-05	0.00655	CbGpPWpGaD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—systemic lupus erythematosus	7.9e-05	0.00643	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	7.86e-05	0.0064	CbGpPWpGaD
Acamprosate—GABRB3—Orphan transporters—RXRA—systemic lupus erythematosus	7.17e-05	0.00584	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—P2RY12—systemic lupus erythematosus	7.14e-05	0.00581	CbGpPWpGaD
Acamprosate—GABRG2—Orphan transporters—RXRA—systemic lupus erythematosus	7.05e-05	0.00574	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—TLR4—systemic lupus erythematosus	6.98e-05	0.00568	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL10—systemic lupus erythematosus	6.93e-05	0.00564	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	6.88e-05	0.0056	CbGpPWpGaD
Acamprosate—GRIN2C—Alzheimers Disease—TNF—systemic lupus erythematosus	6.82e-05	0.00556	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	6.76e-05	0.0055	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—CCR5—systemic lupus erythematosus	6.42e-05	0.00522	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—NR3C1—systemic lupus erythematosus	6.41e-05	0.00522	CbGpPWpGaD
Acamprosate—GRIN2D—Alzheimers Disease—TNF—systemic lupus erythematosus	6.34e-05	0.00517	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—LYN—systemic lupus erythematosus	6.33e-05	0.00515	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—C3—systemic lupus erythematosus	6.27e-05	0.00511	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—LYN—systemic lupus erythematosus	6.17e-05	0.00502	CbGpPWpGaD
Acamprosate—GABRA1—Orphan transporters—RXRA—systemic lupus erythematosus	6.16e-05	0.00501	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—CCL2—systemic lupus erythematosus	5.99e-05	0.00488	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	5.91e-05	0.00481	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—F2—systemic lupus erythematosus	5.5e-05	0.00448	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL1RN—systemic lupus erythematosus	5.48e-05	0.00446	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—PTPRC—systemic lupus erythematosus	5.42e-05	0.00441	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	5.29e-05	0.00431	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—PTPRC—systemic lupus erythematosus	5.28e-05	0.0043	CbGpPWpGaD
Acamprosate—SLC36A1—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	5.28e-05	0.0043	CbGpPWpGaD
Acamprosate—GRIN2A—Alzheimers Disease—TNF—systemic lupus erythematosus	5.21e-05	0.00424	CbGpPWpGaD
Acamprosate—GRIN1—EPH-Ephrin signaling—MMP9—systemic lupus erythematosus	5.14e-05	0.00418	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IFNG—systemic lupus erythematosus	5.09e-05	0.00415	CbGpPWpGaD
Acamprosate—GRIN2B—EPH-Ephrin signaling—MMP9—systemic lupus erythematosus	5.01e-05	0.00408	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	4.93e-05	0.00402	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—CCL2—systemic lupus erythematosus	4.91e-05	0.004	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—PTGS2—systemic lupus erythematosus	4.88e-05	0.00398	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CXCL12—systemic lupus erythematosus	4.8e-05	0.00391	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	4.72e-05	0.00385	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—CDKN1B—systemic lupus erythematosus	4.62e-05	0.00377	CbGpPWpGaD
Acamprosate—GRIN1—EPH-Ephrin signaling—VEGFA—systemic lupus erythematosus	4.61e-05	0.00376	CbGpPWpGaD
Acamprosate—GRIN1—Alzheimers Disease—TNF—systemic lupus erythematosus	4.54e-05	0.0037	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IL2—systemic lupus erythematosus	4.53e-05	0.00369	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—LYN—systemic lupus erythematosus	4.52e-05	0.00368	CbGpPWpGaD
Acamprosate—GRIN2B—EPH-Ephrin signaling—VEGFA—systemic lupus erythematosus	4.5e-05	0.00366	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	4.48e-05	0.00365	CbGpPWpGaD
Acamprosate—GRIN2B—Alzheimers Disease—TNF—systemic lupus erythematosus	4.43e-05	0.00361	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—LYN—systemic lupus erythematosus	4.4e-05	0.00359	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TLR9—systemic lupus erythematosus	4.35e-05	0.00355	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—MMP9—systemic lupus erythematosus	4.28e-05	0.00349	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—P2RY12—systemic lupus erythematosus	4.22e-05	0.00343	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	3.98e-05	0.00324	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL10—systemic lupus erythematosus	3.92e-05	0.00319	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CSK—systemic lupus erythematosus	3.88e-05	0.00316	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—PTPRC—systemic lupus erythematosus	3.87e-05	0.00315	CbGpPWpGaD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—systemic lupus erythematosus	3.86e-05	0.00315	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—JAK1—systemic lupus erythematosus	3.83e-05	0.00312	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—PTPRC—systemic lupus erythematosus	3.77e-05	0.00307	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—JAK1—systemic lupus erythematosus	3.68e-05	0.003	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—ADIPOQ—systemic lupus erythematosus	3.65e-05	0.00297	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—NR3C1—systemic lupus erythematosus	3.63e-05	0.00296	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CCR5—systemic lupus erythematosus	3.63e-05	0.00295	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—JAK1—systemic lupus erythematosus	3.59e-05	0.00292	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	3.57e-05	0.00291	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—ADIPOQ—systemic lupus erythematosus	3.56e-05	0.0029	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NCF2—systemic lupus erythematosus	3.55e-05	0.00289	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—C3—systemic lupus erythematosus	3.54e-05	0.00289	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—TGFB1—systemic lupus erythematosus	3.53e-05	0.00287	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—LYN—systemic lupus erythematosus	3.53e-05	0.00287	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—JAK1—systemic lupus erythematosus	3.47e-05	0.00283	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SH2B3—systemic lupus erythematosus	3.46e-05	0.00282	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—TNF—systemic lupus erythematosus	3.3e-05	0.00268	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CCR5—systemic lupus erythematosus	3.29e-05	0.00268	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—EP300—systemic lupus erythematosus	3.25e-05	0.00264	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL2RA—systemic lupus erythematosus	3.25e-05	0.00264	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—C3—systemic lupus erythematosus	3.22e-05	0.00262	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—RXRA—systemic lupus erythematosus	3.13e-05	0.00255	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—F2—systemic lupus erythematosus	3.11e-05	0.00253	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—VEGFA—systemic lupus erythematosus	3.08e-05	0.00251	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—RXRA—systemic lupus erythematosus	3.05e-05	0.00248	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CXCL12—systemic lupus erythematosus	2.84e-05	0.00231	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—F2—systemic lupus erythematosus	2.83e-05	0.0023	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—JUNB—systemic lupus erythematosus	2.79e-05	0.00227	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	2.68e-05	0.00218	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IL6—systemic lupus erythematosus	2.66e-05	0.00217	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—RASGRP1—systemic lupus erythematosus	2.65e-05	0.00216	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—TNF—systemic lupus erythematosus	2.64e-05	0.00215	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—JAK1—systemic lupus erythematosus	2.63e-05	0.00214	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PRL—systemic lupus erythematosus	2.57e-05	0.00209	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—JAK1—systemic lupus erythematosus	2.56e-05	0.00209	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CCL2—systemic lupus erythematosus	2.52e-05	0.00205	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—TYK2—systemic lupus erythematosus	2.42e-05	0.00197	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—TYK2—systemic lupus erythematosus	2.36e-05	0.00192	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—TYK2—systemic lupus erythematosus	2.29e-05	0.00186	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL6—systemic lupus erythematosus	2.13e-05	0.00173	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—IL2—systemic lupus erythematosus	2.1e-05	0.00171	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—JAK1—systemic lupus erythematosus	2.05e-05	0.00167	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—PPARG—systemic lupus erythematosus	1.97e-05	0.00161	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCR5—systemic lupus erythematosus	1.95e-05	0.00158	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—PPARG—systemic lupus erythematosus	1.92e-05	0.00157	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL2RA—systemic lupus erythematosus	1.92e-05	0.00156	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MMP9—systemic lupus erythematosus	1.91e-05	0.00155	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL2—systemic lupus erythematosus	1.9e-05	0.00155	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—C3—systemic lupus erythematosus	1.9e-05	0.00155	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MMP9—systemic lupus erythematosus	1.86e-05	0.00152	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—EP300—systemic lupus erythematosus	1.84e-05	0.0015	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	1.75e-05	0.00143	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—VEGFA—systemic lupus erythematosus	1.74e-05	0.00142	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TYK2—systemic lupus erythematosus	1.73e-05	0.00141	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	1.72e-05	0.0014	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—VEGFA—systemic lupus erythematosus	1.71e-05	0.0014	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TYK2—systemic lupus erythematosus	1.69e-05	0.00137	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—VEGFA—systemic lupus erythematosus	1.67e-05	0.00136	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—F2—systemic lupus erythematosus	1.67e-05	0.00136	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CD80—systemic lupus erythematosus	1.6e-05	0.0013	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	1.5e-05	0.00122	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—TNF—systemic lupus erythematosus	1.49e-05	0.00122	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCL2—systemic lupus erythematosus	1.49e-05	0.00121	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MMP9—systemic lupus erythematosus	1.36e-05	0.00111	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TYK2—systemic lupus erythematosus	1.35e-05	0.0011	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MMP9—systemic lupus erythematosus	1.33e-05	0.00108	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NOS3—systemic lupus erythematosus	1.33e-05	0.00108	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—EP300—systemic lupus erythematosus	1.29e-05	0.00105	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—EP300—systemic lupus erythematosus	1.26e-05	0.00103	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—VEGFA—systemic lupus erythematosus	1.22e-05	0.000996	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL6—systemic lupus erythematosus	1.2e-05	0.000981	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—VEGFA—systemic lupus erythematosus	1.19e-05	0.000971	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—IL6—systemic lupus erythematosus	1.19e-05	0.000965	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—IL6—systemic lupus erythematosus	1.16e-05	0.000941	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.15e-05	0.000935	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL2—systemic lupus erythematosus	1.12e-05	0.000915	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TGFB1—systemic lupus erythematosus	1.12e-05	0.000914	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL6—systemic lupus erythematosus	1.12e-05	0.000911	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TGFB1—systemic lupus erythematosus	1.09e-05	0.000891	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MMP9—systemic lupus erythematosus	1.06e-05	0.000866	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.06e-05	0.000863	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TNF—systemic lupus erythematosus	1.05e-05	0.000854	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TNF—systemic lupus erythematosus	1.02e-05	0.000832	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—EP300—systemic lupus erythematosus	1.01e-05	0.000821	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	9.94e-06	0.00081	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	9.77e-06	0.000795	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—VEGFA—systemic lupus erythematosus	9.55e-06	0.000778	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TGFB1—systemic lupus erythematosus	8.77e-06	0.000714	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	8.54e-06	0.000695	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—IL6—systemic lupus erythematosus	8.46e-06	0.000689	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—IL6—systemic lupus erythematosus	8.25e-06	0.000672	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL6—systemic lupus erythematosus	6.61e-06	0.000538	CbGpPWpGaD
